Table 3.
Previous meta-analysis of MRI accuracy for diagnosis of glioma recurrence.
| MRI | Study | Pooled Sen and its 95%CI | Pooled Spe and its 95%CI | DOR and its 95%CI | AUC |
|---|---|---|---|---|---|
| Anatomical G-T1-MRI | (13) | 0.68 (0.51,0.81) | 0.77 (0.45,0.93) | NR | NR |
| (64) | 0.48 (0.08,0.90) | 0.85 (0.39,0.98) | NR | NR | |
| ADC of DWI | (13) | 0.71 (0.60,0.80) | 0.87 (0.77,0.93) | NR | NR |
| MRS | (63) | 0.87 (0.80,0.92) | 0.86 (0.77,0.93) | NR | 0.93 |
| (13) | 0.91 (0.79,0.97) | 0.95 (0.65,0.99) | NR | NR | |
| (64) | 0.82 (0.68,0.90) | 0.79 (0.69,0.87) | NR | NR | |
| Cho/NAA of MRS | (11) | 0.88 (0.81,0.93) | 0.86 (0.76,0.93) | 37 (12,84) | 0.92 |
| Cho/Cr of MRS | (11) | 0.83 (0.77,0.89) | 0.83 (0.74,0.90) | 24 (12,49) | 0.90 |
| DSC of PWI | (62) | 0.88 (0.82,0.93) | 0.85 (0.75,0.92) | 42 (19,94) | 0.93 |
| (12) | 0.90 (0.85,0.94) | 0.88 (0.83,0.92) | NR | NR | |
| (13) | 0.87 (0.82,0.91) | 0.86 (0.77,0.91) | NR | NR | |
| DCE of PWI | (12) | 0.89 (0.78,0.96) | 0.85 (0.77,0.91) | NR | NR |
| (13) | 0.92 (0.73,0.98) | 0.85 (0.76,0.92) | NR | NR |
ADC, apparent diffusion coefficient; Cho/Cr, choline/creatine; Cho/NAA, choline/N-acetyl-aspartate; DCE, dynamic contrast-enhanced; DSC, dynamic susceptibility contrast; DWI, diffusion-weighted imaging; G-T1-MRI, gadolinium-enhanced T1-weighted magnetic resonance; MRS, magnetic resonance spectroscopy; PWI, perfusion-weighted imaging; NR, not reported.